Bradykinin is a potent proinflammatory peptide that has been implicated in the pathogenesis of arthritis. We hypothesized that interleukin-1 (IL-1), produced by invading inflammatory cells, upregulates bradykinin responsiveness in target tissues. This was confirmed by showing that IL-1- pretreated human synovial cells produced prostanoids upon exposure to bradykinin, while untreated cells exhibited no significant response. In the current proposal, we seek to determine the mechanism by which bradykinin-responsiveness of synovial cells is induced by IL-1. We propose, based on preliminary data, that two mechanisms may be involved: 1) that IL-1 upregulates the number or affinity of kinin receptors, and 2) that IL-I upregulates one or more post-receptor calcium-dependent processes involved in bradykinin-provoked prostaglandin synthesis. We will use competitive receptor binding assays in intact and broken cells to define the number (Bmax) and affinity (Kd) of kinin receptors and the effect of IL-1 on these parameters. We will use radiolabeling studies in intact cells, and direct enzyme assays in broken cells, to measure the activities of phospholipases A2 and C and protein kinase C in response to bradykinin following preincubation in the presence and absence of IL-1.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Clinical Investigator Award (CIA) (K08)
Project #
1K08AR001856-01
Application #
3079321
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Project Start
1991-09-01
Project End
1996-08-31
Budget Start
1991-09-01
Budget End
1992-08-31
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Faussner, A; Proud, D; Towns, M et al. (1998) Influence of the cytosolic carboxyl termini of human B1 and B2 kinin receptors on receptor sequestration, ligand internalization, and signal transduction. J Biol Chem 273:2617-23
Solan, N J; Ward, P E; Sanders, S P et al. (1998) Soluble recombinant neutral endopeptidase (CD10) as a potential antiinflammatory agent. Inflammation 22:107-21
Austin, C E; Faussner, A; Robinson, H E et al. (1997) Stable expression of the human kinin B1 receptor in Chinese hamster ovary cells. Characterization of ligand binding and effector pathways. J Biol Chem 272:11420-5
Bathon, J M; Chilton, F H; Hubbard, W C et al. (1996) Mechanisms of prostanoid synthesis in human synovial cells: cytokine-peptide synergism. Inflammation 20:537-54
Proud, D; Bathon, J M; Togias, A G et al. (1995) Inhibition of the response to nasal provocation with bradykinin by HOE-140: efficacy and duration of action. Can J Physiol Pharmacol 73:820-6
Bathon, J M; Croghan, J C; MacGlashan Jr, D W et al. (1994) Bradykinin is a potent and relatively selective stimulus for cytosolic calcium elevation in human synovial cells. J Immunol 153:2600-8
Proud, D; Reynolds, C J; Broomfield, J et al. (1993) Bradykinin effects in guinea pig tracheal epithelial cells are mediated through a B2 kinin receptor and can be inhibited by the selective antagonist Hoe 140. J Pharmacol Exp Ther 264:1124-31
Bathon, J M; Manning, D C; Goldman, D W et al. (1992) Characterization of kinin receptors on human synovial cells and upregulation of receptor number by interleukin-1. J Pharmacol Exp Ther 260:384-92
Bathon, J M; Proud, D; Mizutani, S et al. (1992) Cultured human synovial fibroblasts rapidly metabolize kinins and neuropeptides. J Clin Invest 90:981-91